✦ LIBER ✦

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial

✍ Scribed by Sandhu, Shahneen K; Schelman, William R; Wilding, George; Moreno, Victor; Baird, Richard D; Miranda, Susana; Hylands, Lucy; Riisnaes, Ruth; Forster, Martin; Omlin, Aurelius; Kreischer, Nathan; Thway, Khin; Gevensleben, Heidrun; Sun, Linda; Loughney, John; Chatterjee, Manash; Toniatti, Carlo; Carpenter, Christopher L; Iannone, Robert; Kaye, Stan B; de Bono, Johann S; Wenham, Robert M

Book ID: 120608519
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 435 KB
Volume: 14
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(13)70240-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

352 Final Results of the First in Man Tr

352 Final Results of the First in Man Trial of MK4827, a Poly (ADP-ribose) Polymerase (PARP) Inhibitor with Antitumor Activity in BRCA Carriers and Sporadic Cancer Patients

✍ Sandhu, S.K.; Wilding, G.; Schelman, W.R.; Omlin, A.; Kreischer, N.; Carpenter, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

First in human trial of the poly(ADP)-ri

First in human trial of the poly(ADP)-ribose polymerase inhibitor MK-4827 in patients with advanced cancer with antitumor activity in BRCA-deficient and sporadic ovarian cancers

✍ R. Wenham; G. Wilding; R. Baird; L. Sun; C. Toniatti; M. Stroh; C. Carpenter; J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 71 KB

362 First in human trial of a poly(ADP)-

362 First in human trial of a poly(ADP)-ribose polymerase (PARP) inhibitor MK-4827 in advanced cancer patients (p) with antitumor activity in BRCA-deficient and sporadic ovarian cancers

✍ R.M. Wenham; S.K. Sandhu; G. Wilding; L. Sun; C. Toniatti; M. Stroh; C. Carpente 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Oral poly(ADP-ribose) polymerase inhibit

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

✍ Andrew Tutt; Mark Robson; Judy E Garber; Susan M Domchek; M William Audeh; Jeffr 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 594 KB

Oral poly(ADP-ribose) polymerase inhibit

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

✍ M William Audeh; James Carmichael; Richard T Penson; Michael Friedlander; Bethan 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 268 KB

Oral poly(ADP-ribose) polymerase inhibit

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

✍ Gelmon, K.A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 107 KB